CDLX Relative Valuation
CDLX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CDLX is overvalued; if below, it's undervalued.
Historical Valuation
Cardlytics Inc (CDLX) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -15.33. The fair price of Cardlytics Inc (CDLX) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：1.23
Fair
-3.27
PE
1Y
3Y
5Y
Trailing
Forward
18.63
EV/EBITDA
Cardlytics Inc. (CDLX) has a current EV/EBITDA of 18.63. The 5-year average EV/EBITDA is -125.08. The thresholds are as follows: Strongly Undervalued below -922.83, Undervalued between -922.83 and -523.96, Fairly Valued between 273.80 and -523.96, Overvalued between 273.80 and 672.67, and Strongly Overvalued above 672.67. The current Forward EV/EBITDA of 18.63 falls within the Historic Trend Line -Fairly Valued range.
-15.03
EV/EBIT
Cardlytics Inc. (CDLX) has a current EV/EBIT of -15.03. The 5-year average EV/EBIT is 27.71. The thresholds are as follows: Strongly Undervalued below -397.60, Undervalued between -397.60 and -184.94, Fairly Valued between 240.37 and -184.94, Overvalued between 240.37 and 453.03, and Strongly Overvalued above 453.03. The current Forward EV/EBIT of -15.03 falls within the Historic Trend Line -Fairly Valued range.
0.31
PS
Cardlytics Inc. (CDLX) has a current PS of 0.31. The 5-year average PS is 3.73. The thresholds are as follows: Strongly Undervalued below -5.93, Undervalued between -5.93 and -1.10, Fairly Valued between 8.56 and -1.10, Overvalued between 8.56 and 13.39, and Strongly Overvalued above 13.39. The current Forward PS of 0.31 falls within the Historic Trend Line -Fairly Valued range.
3.98
P/OCF
Cardlytics Inc. (CDLX) has a current P/OCF of 3.98. The 5-year average P/OCF is -22.73. The thresholds are as follows: Strongly Undervalued below -410.78, Undervalued between -410.78 and -216.75, Fairly Valued between 171.30 and -216.75, Overvalued between 171.30 and 365.33, and Strongly Overvalued above 365.33. The current Forward P/OCF of 3.98 falls within the Historic Trend Line -Fairly Valued range.
-39.62
P/FCF
Cardlytics Inc. (CDLX) has a current P/FCF of -39.62. The 5-year average P/FCF is 683.79. The thresholds are as follows: Strongly Undervalued below -5222.47, Undervalued between -5222.47 and -2269.34, Fairly Valued between 3636.92 and -2269.34, Overvalued between 3636.92 and 6590.05, and Strongly Overvalued above 6590.05. The current Forward P/FCF of -39.62 falls within the Historic Trend Line -Fairly Valued range.
Cardlytics Inc (CDLX) has a current Price-to-Book (P/B) ratio of -14.07. Compared to its 3-year average P/B ratio of 0.34 , the current P/B ratio is approximately -4198.05% higher. Relative to its 5-year average P/B ratio of 2.65, the current P/B ratio is about -631.47% higher. Cardlytics Inc (CDLX) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -8.58%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -6.90% , the current FCF yield is about -100.00% lower.
-13.84
P/B
Median3y
0.34
Median5y
2.65
-1.98
FCF Yield
Median3y
-8.58
Median5y
-6.90
Competitors Valuation Multiple
The average P/S ratio for CDLX's competitors is , providing a benchmark for relative valuation. Cardlytics Inc Corp (CDLX) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of -22.41%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of CDLX decreased by 67.39% over the past 1 year. The primary factor behind the change was an increase in P/E Change from -0.63 to -0.57.
The secondary factor is the Revenue Growth, contributed -22.41%to the performance.
Overall, the performance of CDLX in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is Cardlytics Inc (CDLX) currently overvalued or undervalued?
What is Cardlytics Inc (CDLX) fair value?
How does CDLX's valuation metrics compare to the industry average?
What is the current P/B ratio for Cardlytics Inc (CDLX) as of Dec 05 2025?
What is the current FCF Yield for Cardlytics Inc (CDLX) as of Dec 05 2025?
What is the current Forward P/E ratio for Cardlytics Inc (CDLX) as of Dec 05 2025?